Literature DB >> 31724465

Antiviral bioactivity of renewable polysaccharides against Varicella Zoster.

Eiman Abu-Galiyun1, Mahmoud Huleihel2, Oshrat Levy-Ontman1.   

Abstract

Although several effective treatments exist against Varicella zoster virus (VZV), resistant strains have emerged and the treatment is usually not definite and may have various undesired side effects. Thus, alternative treatment options are necessary. Here we studied the inhibitory effects of natural polysaccharides (PSs) obtained from renewable sources, varied by their structure and charge, on VZV infection in vitro, using a plaque assay. In terms of selectivity indices, almost all the tested PSs were very active; in the order of λ > ἰ > G > κ > P against VZV compared to Acyclovir as a reference drug and exhibited dose-dependent behavior. Our results, which showed a strong inhibition of VZV infection when the cells were treated with ἰ only at the time of infection or only post infection may indicate a multistep inhibitory effect. It seems that ἰ may block different stages of the virus replication cycle including early steps such as absorption and penetration to the host cells and also late steps after the penetration into the host cells. These results are part of an on-going research that highlights the PSs as potential novel nontoxic candidates that can be used against VZV, and contributes to the elucidation of their mode of action.

Entities:  

Keywords:  Anti-viral; Varicella zoster virus; carrageenan; renewable polysaccharides; sulfated polysaccharides

Year:  2019        PMID: 31724465      PMCID: PMC6927708          DOI: 10.1080/15384101.2019.1691363

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  41 in total

Review 1.  Carrageenan-induced paw edema in the rat and mouse.

Authors:  Christopher J Morris
Journal:  Methods Mol Biol       Date:  2003

2.  Polysaccharides as antiviral agents: antiviral activity of carrageenan.

Authors:  M E González; B Alarcón; L Carrasco
Journal:  Antimicrob Agents Chemother       Date:  1987-09       Impact factor: 5.191

Review 3.  Natural products as a resource for new drugs.

Authors:  A M Clark
Journal:  Pharm Res       Date:  1996-08       Impact factor: 4.200

Review 4.  Herpes simplex virus infections.

Authors:  R J Whitley; B Roizman
Journal:  Lancet       Date:  2001-05-12       Impact factor: 79.321

Review 5.  Varicella-zoster virus infection: natural history, clinical manifestations, immunity and current and future vaccination strategies.

Authors:  Giulia Freer; Mauro Pistello
Journal:  New Microbiol       Date:  2018-03-02       Impact factor: 2.479

6.  Multicenter collaborative trial of intravenous acyclovir for treatment of mucocutaneous herpes simplex virus infection in the immunocompromised host.

Authors:  J D Meyers; J C Wade; C D Mitchell; R Saral; P S Lietman; D T Durack; M J Levin; A C Segreti; H H Balfour
Journal:  Am J Med       Date:  1982-07-20       Impact factor: 4.965

7.  Antiviral activity of ethanol extracts of Ficus binjamina and Lilium candidum in vitro.

Authors:  Ludmila Yarmolinsky; Michele Zaccai; Shimon Ben-Shabat; David Mills; Mahmoud Huleihel
Journal:  N Biotechnol       Date:  2009-08-22       Impact factor: 5.079

8.  Relapsing Herpes simplex virus encephalitis despite high-dose acyclovir therapy: a case report.

Authors:  Ilker Devrim; Hasan Tezer; Göknur Haliloğlu; Ateş Kara; Gülten Seçmeer
Journal:  Turk J Pediatr       Date:  2008 Jul-Aug       Impact factor: 0.552

9.  Evaluation of antiviral activity of South American plant extracts against herpes simplex virus type 1 and rabies virus.

Authors:  Vanessa Müller; Juliana H Chávez; Flávio H Reginatto; Silvana M Zucolotto; Rivaldo Niero; Dionezine Navarro; Rosendo A Yunes; Eloir P Schenkel; Célia R M Barardi; Carlos R Zanetti; Cláudia M O Simões
Journal:  Phytother Res       Date:  2007-10       Impact factor: 5.878

10.  Iota-carrageenan is a potent inhibitor of influenza A virus infection.

Authors:  Andreas Leibbrandt; Christiane Meier; Marielle König-Schuster; Regina Weinmüllner; Donata Kalthoff; Bettina Pflugfelder; Philipp Graf; Britta Frank-Gehrke; Martin Beer; Tamas Fazekas; Hermann Unger; Eva Prieschl-Grassauer; Andreas Grassauer
Journal:  PLoS One       Date:  2010-12-14       Impact factor: 3.240

View more
  4 in total

Review 1.  Carrageenans as Broad-Spectrum Microbicides: Current Status and Challenges.

Authors:  Choongho Lee
Journal:  Mar Drugs       Date:  2020-08-21       Impact factor: 5.118

Review 2.  Carrageenan: Drug Delivery Systems and Other Biomedical Applications.

Authors:  Edisson-Mauricio Pacheco-Quito; Roberto Ruiz-Caro; María-Dolores Veiga
Journal:  Mar Drugs       Date:  2020-11-23       Impact factor: 5.118

Review 3.  The Antiviral Activity of Bacterial, Fungal, and Algal Polysaccharides as Bioactive Ingredients: Potential Uses for Enhancing Immune Systems and Preventing Viruses.

Authors:  Worraprat Chaisuwan; Yuthana Phimolsiripol; Thanongsak Chaiyaso; Charin Techapun; Noppol Leksawasdi; Kittisak Jantanasakulwong; Pornchai Rachtanapun; Sutee Wangtueai; Sarana Rose Sommano; SangGuan You; Joe M Regenstein; Francisco J Barba; Phisit Seesuriyachan
Journal:  Front Nutr       Date:  2021-11-05

Review 4.  Antiviral Activity of Carrageenans and Processing Implications.

Authors:  Milena Álvarez-Viñas; Sandra Souto; Noelia Flórez-Fernández; Maria Dolores Torres; Isabel Bandín; Herminia Domínguez
Journal:  Mar Drugs       Date:  2021-07-30       Impact factor: 5.118

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.